Chattem VP/CFO
This article was originally published in The Rose Sheet
Executive Summary
Richard Moss appointed vice president, CFO effective Sept. 1, health and beauty aids manufacturer announces Aug. 8. Moss brings to firm 19 years of senior-level corporate finance and treasury experience, serving as vice president and treasurer of Sealy Corporation and in various treasury and finance positions at Ansaldo Signal, Union Switch & Signal and GM/Saturn. Chattem manufactures and markets over the counter products including Gold Bond, Selsun Blue, pHisoderm and Dexatrim...
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.